Status:
TERMINATED
Virtual Reality Education Program to Reduce Anxiety During Radiation Therapy
Lead Sponsor:
Medical College of Wisconsin
Collaborating Sponsors:
Marquette University
Froedtert Hospital
Conditions:
Anxiety
Stress
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the efficacy of an immersive virtual reality (VR)-based education program with a form of patient education commonly provided by clinics (e.g., an educational vi...
Detailed Description
Breast cancer patients experience anxiety, potentially reaching levels that are considered clinically-relevant. Prior research in this area has described the information needs of breast cancer patient...
Eligibility Criteria
Inclusion
- Patient is 18 years of age or older
- Patient is female
- Patient has been diagnosed with breast cancer
- Patient will be receiving whole breast radiation therapy without supraclavicular nodal irradiation
- Patient is scheduled for an outpatient radiation oncology visit
- Patient has the ability to understand a written informed consent document, and the willingness to sign it
- Patient has the ability to complete a series of self-reported questionnaires
Exclusion
- Non-English-speaking patients (as the VR education program includes English narration)
- Patients with visual defects that affect their ability to watch a movie
- Patients with auditory defects that affect their ability to listen with headphones
- Patients who have worked in the field of radiation oncology as they would have previously undergone treatment-related education
- Patients who have been treated previously with radiation oncology as they would have previously undergone treatment-related education
- Patients that have been diagnosed with epilepsy, conditions causing seizures, or have any previous history of seizures because a very minute number of head-mounted display (HMD) users have experienced a seizure as a result of using the device
- Patients with a reported history of cognitive disability as their ability to understand educational content may be impaired
- Patients with a history of severe motion sickness because a side effect of using a HMD in a very small number of users is motion sickness symptoms
- Patients with a pacemaker, hearing aid(s), and/or defibrillator, while patients with other types of electronic medical devices / implants will be assessed for eligibility on a case-by-case basis because there could be potential interference with the HMD
Key Trial Info
Start Date :
August 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 14 2020
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04029961
Start Date
August 12 2019
End Date
April 14 2020
Last Update
May 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Froedtert & the Medical College of Wisconsin
Milwaukee, Wisconsin, United States, 53226